Tango Therapeutics, Inc. (TNGX)

NASDAQ: TNGX · Real-Time Price · USD

20.24

-1.38 (-6.38%)

At close: May 22, 2026, 4:00 PM EDT

20.30

+0.06 (0.30%)

After-hours: May 22, 2026, 7:32 PM EDT

Tango Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	2,928	1,204	333	1,012	639	958
Market Cap Growth	2361.91%	261.82%	-67.10%	58.27%	-33.29%	107.49%
Enterprise Value	2,581	892.13	109.01	711.76	312.53	473.07
Last Close Price	20.24	8.86	3.09	9.90	7.25	10.94
PS Ratio	51.37	19.31	7.91	27.70	25.72	25.87
PB Ratio	7.45	3.48	1.67	4.00	2.56	2.78
P/TBV Ratio	6.51	2.97	1.69	3.70	2.55	1.97
EV/Sales Ratio	45.28	14.30	2.59	19.49	12.57	12.77
Debt / Equity Ratio	0.08	0.09	0.17	0.15	0.16	0
Net Debt / Equity Ratio	-0.89	-0.89	-1.11	-1.18	-1.30	-1.40
Net Debt / EBITDA Ratio	3.01	2.84	1.55	2.67	2.97	8.44
Net Debt / FCF Ratio	2.44	2.21	1.67	2.49	2.78	7.88
Asset Turnover	0.14	0.17	0.12	0.09	0.05	0.10
Quick Ratio	26.51	15.83	6.76	7.33	6.63	11.97
Current Ratio	27.38	16.32	6.98	7.54	6.76	12.10
Return on Equity (ROE)	-29.09%	-37.23%	-57.41%	-40.39%	-36.37%	-30.08%
Return on Assets (ROA)	-28.18%	-31.12%	-40.43%	-27.18%	-23.71%	-16.37%
Return on Invested Capital (ROIC)	-290.04%	-288.72%	-330.47%	-237.83%	-442.50%	-1078.35%
Return on Capital Employed (ROCE)	-29.44%	-33.96%	-45.86%	-30.96%	-26.43%	-18.60%
Buyback Yield / Dilution	-13.42%	-6.35%	-15.50%	-7.69%	-41.40%	-94.50%
Total Shareholder Return	-13.42%	-6.35%	-15.50%	-7.69%	-41.40%	-94.50%

Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q